Inquirer on MSN3d
US approves 1st fast-acting insulin biosimilar for diabetesThe US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls ...
Metformin is the most commonly prescribed oral drug for diabetes. Of course, if you or a loved one receives treatment for ...
6don MSN
Why it matters: More than 3.5 million Californians have diabetes, and insulin is a life-saving part of their disease ...
The Punch on MSN4d
NAFDAC alerts Nigerians on circulation of substandard insulin syringesThe National Agency for Food and Drug Administration and Control has raised the alarm over the illegal circulation and ...
Biocon Biologics has partnered with Civica to improve access to and affordability of insulin aspart in the U.S. Biocon will ...
Biocon Biologics partners with Civica to enhance access to Insulin Aspart in the US, no tech transfer involved.
People on Ozempic and other GLP-1 agonist drugs commonly report they no longer have constant, incessant thoughts about food.
During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...
The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.
The Healthy on MSN5d
More Than 900,000 Diabetes Devices Have Been Recalled NationwideAccording to 2021 data from the American Diabetes Association, 2 million Americans have type 1 diabetes—304,000 of which are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback